** = Publikationen gelistet in SCI/SSCI/Pubmed
** Idris, T; Benedicic, C; Schest, E; Lang, U; Petru, E
Fulminant Course of Disease in primary Lungmetastases of a Trophoblast Tumor
GEBURTSH FRAUENHEILK. 2012; 72(4):
[Keynote lecture]
Web of Science
** Idris, T; Volgger, B; Sallinger, G; Schauer, C; Pfleger, U; Neuwirth, M; Kreische, S; Marth, C; Petru, E
Non-acceptable Toxicity Profile in the randomized Phase-II-Study with liposomal Doxorubicin +/- Gemcitabine plus prophylactic G-CSF-Administration (AGO Austria 10) in platin-resistant Recurrent Ovarian Cancer
GEBURTSH FRAUENHEILK. 2012; 72(4):
[Keynote lecture]
Web of Science
** Schest, E; Idris, T; Benedicic, C; Lanz-Veit, A; Petru, E
4 Years of Tumor stabilization after early recurrence of cervical cancer in a 30-year-old woman
GEBURTSH FRAUENHEILK. 2012; 72(4):
[Keynote lecture]
Web of Science
** Schest, E; Idris, T; Benedicic, C; Lanz-Veit, A; Tamussino, K; Petru, E
Long-term Remission following Treatment of a recurring Breast Cancer with palliative Radiation Therapy, Lapatinib and Fulvestrant: A Case Report
GEBURTSH FRAUENHEILK. 2012; 72(4):
[Keynote lecture]
Web of Science
** Idris, T; Krippl, P; Lang, U; Petru, E
Long-Term Disease Control with Lapatinib and Capecitabine in a Heavily Pretreated Patient with ErbB2-Positive Metastatic Breast Cancer.
Breast Care (Basel). 2010; 5(5):335-337
Doi: 10.1159/000321394
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Idris, T; Hartner, E; Krippl, P; Lang, U; Petru, E
Long-Tumorstabilisation a Her-2-neu positive, metastatic breast cancer patient with Lapatinib and Capecitabine.
GEBURTSH FRAUENHEILK. 2010; 70(5):P49-
[Keynote lecture]
Web of Science
** Idris, T; Hartner, E; Krippl, P; Lang, U; Petru, E
Long-tern survival of a Her-2-ner-positive breast cancer patients under the Lapatinic and Cepesitabin despite the various pretreatments
GEBURTSH FRAUENHEILK. 2010; 70(3): 244-244.
[Poster]
Web of Science
** Idris, T; Winter, R; Lang, U; Petru, E
Topotecan-induced long-term remission of an advanced endometrial cancer after treatment with cisplatinum, an anthracycline and paclitaxel.
ANTICANCER RES. 2009; 29(5): 1761-1762.
(- Case Report)
[OPEN ACCESS]
Web of Science
PubMed
FullText
Google Scholar